- Paper diagnostics, which utilize cellulose-based substrates to conduct biochemical tests, are becoming increasingly vital in modern healthcare diagnostics due to their low cost, portability, ease of use, and suitability for point-of-care applications, especially in resource-limited settings
- The accelerating demand for paper diagnostics is primarily driven by the rising prevalence of infectious diseases, increased global focus on early disease detection, and the growing need for decentralized diagnostic solutions that minimize dependency on complex lab infrastructure
- North America dominates the paper diagnostics market with the largest revenue share of 38.5% in 2024, characterized by strong healthcare infrastructure, early adoption of innovative diagnostic technologies, and significant investments in R&D from both public and private sectors
- Asia-Pacific is expected to be the fastest growing region in the paper diagnostics market during the forecast period due to the expanding healthcare access, rising government initiatives for affordable diagnostics, and increasing demand for low-cost solutions in densely populated countries such as India and China
- Lateral flow assays segment dominates the paper diagnostics market with a market share of 46.5% in 2024, driven by its wide usage in pregnancy tests, COVID-19 antigen tests, and other rapid diagnostic kits, supported by high scalability, minimal training requirements, and rapid result turnaround
